Skip to Content
Center for International Blood and Marrow Transplant Research

IB10-01r

Main Content

Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders

Study #: IB10-01r

Study Status: Published


Germline pathogenic variants in MUTYH are associated with inferior survival after hematopoietic cell transplantation in patients with hematologic malignancies or disorders.

Citation

Rafati M, Wang Y, Koppayi AL, Savage SA, Godley LA, Williams KM, Porter C, Jones K, Hicks B, Spellman SR, He M, Atshan R, Iwuagwu C, Bolon YT, Arrieta-Bolaños E, Saultz JN, Benjamin CL, Lee SJ, Saber W, Gadalla SM.

American Journal of Hematology. 2025, Oct 03: (): . doi: 10.1002/ajh.70093. Epub 2025, Oct 03. PMCID:.

PubMed

PMID: 41042026

Abstract